image
Sonnet BioTherapeutics Holdings, Inc. SONN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.02
0.667 %
$ 2.53 M
Market Cap
-3.15
P/E
INCOME STATEMENT
148 K REVENUE
-57.76%
Growth Rates
1Year -57.76%
3Years 0.00%
5Years -65.61%
7Years -55.34%
10Years -37.96%
-18.8 M OPERATING INCOME
36.66%
Growth Rates
1Year 36.66%
3Years 8.13%
5Years -43.66%
7Years -32.51%
10Years -12.48%
-18.8 M NET INCOME
36.64%
Growth Rates
1Year 36.64%
3Years 8.10%
5Years -22.37%
7Years -23.61%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Sonnet BioTherapeutics Holdings, Inc.
image
Revenue 148 K
Cost Of Revenue 11.8 M
Gross Profit -11.7 M
Operating Expenses 7.13 M
Operating Income -18.8 M
Other Expenses 40.1 K
Net Income -18.8 M

Income Statement

Millions
Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 0.1 0.3 0.5 0 40.6 30.7 41.4 41.7 42.4 0 17.5
GROSS PROFIT
Cost Of Revenue 11.8 93.3 K 16.6 58.3 K 7.9 29.9 39.4 38.4 14.0 0 0
Gross Profit (11.7) 0.3 (16.2) 58.3 K 32.7 0.8 2.0 3.3 28.4 0 17.5
OPERATING INCOME
Operating Expenses 7.1 30.0 25.6 17.4 4.7 3.9 4.5 5.9 10.8 0 (23.3)
Selling, General and Administrative Expenses 7.1 8.6 8.9 7.5 2.5 3.9 4.5 5.9 7.4 0 0
Research and Development Expenses 11.8 21.4 16.6 9.9 2.2 0.2 0 0 0 0 0
Operating Income (18.8) (29.7) (25.1) (24.2) (4.7) (3.1) (2.5) (2.6) (11.5) 0 (5.8)
PRE-TAX INCOME
Interest Income Expense 0 40.8 K 0 20.7 K (2.5) (2.5) (2.6) (2.3) (3.5) 0 0
Total Other Income 40.1 K 52.5 K 0.1 27.3 K (0.2) (7.4) (5.3) (1.5) 3.6 0 0.5
Pre-Tax Income (18.8) (29.7) (25.0) (24.3) (4.9) (8.1) (7.8) (4.1) (14.3) 0 (6.0)
NET INCOME
Tax Provision 0 52.5 K 22 K 6.8 0.2 (0.7) (0.6) 0.2 (0.2) 0 0
Net Income (18.8) (29.8) (25.0) (31.1) (5.0) (6.9) (6.8) (9.1) (12.1) 0 (6.0)
EPS 18.1 151 314 1.02 K 5.78 K 15.6 K 21.5 K 33.5 K 42.6 K 0 68.3 K